Bausch Health to Announce Third Quarter 2025 Results on October 29
-
Alcaraz out of Shanghai after winning eighth title of season
-
Nche starts for South Africa as they eye Rugby Championship title against Argentina
-
AI tool helps researchers treat child epilepsy
-
US stocks fall as government shutdown looms
-
Brigitte Bardot slams Saint-Tropez after decades in jet-set port
-
Pentagon chief tells US military leaders to fix 'decades of decay'
-
Spotify founder Daniel Ek to give up CEO role
-
Barca star Yamal must 'work hard' to reach top level, says Flick
-
EU green lights Prada's bid for Versace
-
New youth-led protests in Madagascar despite government's dismissal
-
Sinner to face teenager Tien in Beijing final as Gauff battles on
-
Typhoon Bualoi inflicts death, lasting floods on Vietnam
-
Gold hits record, dollar drops as US shutdown looms
-
Hamas reviewing Trump's Gaza plan
-
Alcaraz beats Fritz in Tokyo for eighth title of season
-
Lingering Typhoon Bualoi inflicts death, flooding on Vietnam
-
Vietnam jails former officials over gold bar graft: state media
-
German far-right MP's ex aide jailed for spying for China
-
Who will take 30,000 asylum seekers? EU solidarity faces big test
-
PSG's Kvaratskhelia to miss Barcelona Champions League trip
-
Endometriosis test backed by French government under scrutiny
-
Madagascar protesters undeterred despite sacking of government
-
Saliba signs new long-term deal at Arsenal
-
Sinner powers into Beijing final as Gauff survives Bencic test
-
Madagascar protesters mobilise despite firing of government
-
Gauff calls for shorter tennis seasons as 'impossible' to play more
-
Hamas yet to respond on Trump's Gaza plan
-
Long-lasting Typhoon Bualoi devastates Vietnam, killing 19
-
Dozens missing, three dead in Indonesia school collapse
-
India hot favourites for home Tests against struggling West Indies
-
Taliban internet cut sparks Afghanistan telecoms blackout
-
Gold hits record, stocks mixed as US shutdown looms
-
San Siro on course for demolition after sale to Inter and AC Milan approved
-
Trial opens over Bangkok murder of French-Cambodian ex-MP
-
Gauff survives tense Bencic test to reach Beijing quarter-finals
-
US careens toward government shutdown as both parties dig in
-
Wolf attack in Greece prompts calls for hunting rights
-
Trump to address rare mass meeting of US military leaders
-
Iranian director Jafar Panahi defies censors again with new film
-
Taliban impose communications blackout across Afghanistan
-
Barca's Yamal eyes up PSG after Ballon d'Or miss
-
PSG facing injury crisis as Barcelona present first big test
-
British bettor Bloom's football empire blossoming with Belgian club USG
-
US tariffs on lumber imports set for October 14
-
Australia lose Maxwell for New Zealand T20s after freak net blow
-
India plans mega-dam to counter China water fears
-
Colombia manufactures its first rifles to replace Israeli weapons
-
Stocks rise, gold hits record as rate cuts and shutdown loom
-
Dolphins star Hill suffers gruesome injury in Jets clash
-
Paralympics' vote to lift Russian suspension 'bold step' as conflict rages: ex-IOC executive
NYSE - LSE
Bausch Health to Announce Third Quarter 2025 Results on October 29
LAVAL, QC / ACCESS Newswire / September 30, 2025 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) will release third quarter 2025 financial results after market close on Wednesday, October 29, 2025. Bausch Health will host a live conference call and webcast at 5:00 p.m. U.S. EDT to discuss results and provide a business update. All materials will be made available on the Investor Relations section of the Bausch Health website prior to the start of the call.
Conference Call Details
Date: | Wednesday, October 29, 2025 |
Time: | 5:00 p.m. U.S. EDT |
Webcast: |
A replay of the conference call will be available on the investor relations website.
About Bausch Health
Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) is a global diversified pharmaceutical company enriching lives through our relentless drive to deliver better health care outcomes. We develop, manufacture and market a range of products primarily in gastroenterology, hepatology, neurology, dermatology, dentistry, aesthetics, international pharmaceuticals and eye health, through our controlling interest in Bausch + Lomb. Our ambition is to be a globally integrated healthcare company, trusted and valued by patients, HCPs, employees and investors. For more information, visit www.bauschhealth.com and connect with us on LinkedIn.
###
Investor Contact: | Media Contact: |
Garen Sarafian | Katie Savastano |
(877) 281-6642 (toll-free) | (908) 541-3785 |
SOURCE: Bausch Health Companies Inc.
View the original press release on ACCESS Newswire
M.A.Colin--AMWN